Advances in non-Hodgkin lymphoma treatment lag behind Hodgkin's disease due to classification issues. Standardized staging and histology guide tailored therapies, improving patient outcomes for specific lymphoma types.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: